ea0077op3.1 | Reproductive and Neuroendocrinology | SFEBES2021
Abeyaratne Dayakshi
, Kaniuka-Jakubowska Sonia
, Plummer Zoe
, Archer Natasha
, Lakmal Fonseka Chathuranga
, Ayuk John
, Peter James
, McNally Richard
, Michael Orme Stephen
, Rees Aled
, Pal Aparna
, Wass John
Background: Growth hormone (GH) and Insulin like growth factor 1 (IGF-1) discordance in patients with acromegaly is a well-recognised phenomenon. It is unclear whether this is associated with increased mortality and morbidity compared to patients with concordant normal results.Methodology: A retrospective study was conducted on the United Kingdom Acromegaly Registry (UKAR). A comparison of mortality and morbidity was performed among four groups categoris...